Post-finasteride syndrome,

Abstract Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related re...

Full description

Bibliographic Details
Main Authors: Ana Francisca Junqueira Ribeiro Pereira, Thaissa Oliveira de Almeida Coelho
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2020-07-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000300001&tlng=en
_version_ 1819261175255269376
author Ana Francisca Junqueira Ribeiro Pereira
Thaissa Oliveira de Almeida Coelho
author_facet Ana Francisca Junqueira Ribeiro Pereira
Thaissa Oliveira de Almeida Coelho
author_sort Ana Francisca Junqueira Ribeiro Pereira
collection DOAJ
description Abstract Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related reactions that persisted for at least three months after discontinuation of this drug, and the term post-finasteride syndrome arose. It includes persistent sexual, neuropsychiatric, and physical symptoms. Studies to date cannot refute or confirm this syndrome as a nosological entity. If it actually exists, it seems to occur in susceptible people, even if exposed to small doses and for short periods, and symptoms may persist for long periods. Based on currently available data, the use of 5α-reductase inhibitors in patients with a history of depression, sexual dysfunction, or infertility should be carefully and individually assessed.
first_indexed 2024-12-23T19:37:37Z
format Article
id doaj.art-72ec3ebc94b649c889b6ac071870e70f
institution Directory Open Access Journal
issn 0365-0596
language English
last_indexed 2024-12-23T19:37:37Z
publishDate 2020-07-01
publisher Sociedade Brasileira de Dermatologia
record_format Article
series Anais Brasileiros de Dermatologia
spelling doaj.art-72ec3ebc94b649c889b6ac071870e70f2022-12-21T17:33:44ZengSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia0365-05962020-07-0195327127710.1016/j.abd.2020.02.001Post-finasteride syndrome,Ana Francisca Junqueira Ribeiro Pereirahttps://orcid.org/0000-0003-1161-8810Thaissa Oliveira de Almeida Coelhohttps://orcid.org/0000-0002-2755-1094Abstract Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related reactions that persisted for at least three months after discontinuation of this drug, and the term post-finasteride syndrome arose. It includes persistent sexual, neuropsychiatric, and physical symptoms. Studies to date cannot refute or confirm this syndrome as a nosological entity. If it actually exists, it seems to occur in susceptible people, even if exposed to small doses and for short periods, and symptoms may persist for long periods. Based on currently available data, the use of 5α-reductase inhibitors in patients with a history of depression, sexual dysfunction, or infertility should be carefully and individually assessed.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000300001&tlng=en5-Alpha reductase inhibitorsAlopeciaFinasteride
spellingShingle Ana Francisca Junqueira Ribeiro Pereira
Thaissa Oliveira de Almeida Coelho
Post-finasteride syndrome,
Anais Brasileiros de Dermatologia
5-Alpha reductase inhibitors
Alopecia
Finasteride
title Post-finasteride syndrome,
title_full Post-finasteride syndrome,
title_fullStr Post-finasteride syndrome,
title_full_unstemmed Post-finasteride syndrome,
title_short Post-finasteride syndrome,
title_sort post finasteride syndrome
topic 5-Alpha reductase inhibitors
Alopecia
Finasteride
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000300001&tlng=en
work_keys_str_mv AT anafranciscajunqueiraribeiropereira postfinasteridesyndrome
AT thaissaoliveiradealmeidacoelho postfinasteridesyndrome